A review on the molecular basis underlying the protective effects of Andrographis paniculata and andrographolide against myocardial injury
- PMID: 34785890
- PMCID: PMC8591231
- DOI: 10.2147/DDDT.S331027
A review on the molecular basis underlying the protective effects of Andrographis paniculata and andrographolide against myocardial injury
Abstract
Andrographolide is the major compound found in the medicinal plant, Andrographis paniculata (Burm.f.) Nees, which accounts for its medicinal properties. Both the plant extract and compound have been reported to exhibit potential cardiovascular activities. This review summarises related studies describing the biological activities and target mechanisms of A. paniculata and andrographolide in vivo and in vitro. The current evidence unambiguously indicated the protective effects provided by A. paniculata and andrographolide administration against myocardial injury. The intervention ameliorates the symptoms of myocardial injury by interfering with the inductive phase of a) inflammatory response mediated by nuclear factor-kappa B (NF-κB), phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt), mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription 3 (STAT3) signalling molecules; b) oxidative stress via activation of nuclear factor erythroid 2-related factor (Nrf-2) and reduction of enzymes responsible for generating reactive oxygen and nitrogen species; c) intrinsic and extrinsic mechanisms in apoptosis regulated by upstream insulin-like growth factor-1 receptor (IGF-1R) and peroxisome proliferator-activated receptor-alpha (PPAR-α); d) profibrotic growth factors thus reducing cardiac fibrosis, improving endothelial function and fibrinolytic function. In conclusion, A. paniculata and andrographolide possess therapeutic potential in the management of myocardial injury, which requires further validation in human clinical trials.
Keywords: Andrographis; apoptosis; fibrosis; inflammation; myocardial infarction; oxidative stress.
© 2021 Wong et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures






Similar articles
-
Protective effect of the effective part of Andrographis paniculata (Burm.f.) Nees on PM2.5-induced lung injury in rats by modulating the NF-κB pathway.J Ethnopharmacol. 2021 Nov 15;280:114420. doi: 10.1016/j.jep.2021.114420. Epub 2021 Jul 13. J Ethnopharmacol. 2021. PMID: 34271116
-
Identification and characterization of new potent inhibitors of dengue virus NS5 proteinase from Andrographis paniculata supercritical extracts on in animal cell culture and in silico approaches.J Ethnopharmacol. 2021 Mar 1;267:113541. doi: 10.1016/j.jep.2020.113541. Epub 2020 Nov 2. J Ethnopharmacol. 2021. PMID: 33152438
-
Andrographolide and its derivatives are effective compounds for gastrointestinal protection: a review.Eur Rev Med Pharmacol Sci. 2021 Mar;25(5):2367-2382. doi: 10.26355/eurrev_202103_25276. Eur Rev Med Pharmacol Sci. 2021. PMID: 33755974 Review.
-
Effect of andrographolide and deep eutectic solvent extracts of Andrographis paniculata on human coronavirus organ culture 43 (HCoV-OC43).Phytomedicine. 2023 Apr;112:154708. doi: 10.1016/j.phymed.2023.154708. Epub 2023 Feb 8. Phytomedicine. 2023. PMID: 36805485 Free PMC article.
-
Andrographolide and analogues in cancer prevention.Front Biosci (Elite Ed). 2015 Jan 1;7(2):255-66. doi: 10.2741/E732. Front Biosci (Elite Ed). 2015. PMID: 25553378 Review.
Cited by
-
Andrographolide Inhibits Corneal Fibroblast to Myofibroblast Differentiation In Vitro.Biomolecules. 2022 Oct 9;12(10):1447. doi: 10.3390/biom12101447. Biomolecules. 2022. PMID: 36291655 Free PMC article.
-
Medicinal Plant Extracts against Cardiometabolic Risk Factors Associated with Obesity: Molecular Mechanisms and Therapeutic Targets.Pharmaceuticals (Basel). 2024 Jul 21;17(7):967. doi: 10.3390/ph17070967. Pharmaceuticals (Basel). 2024. PMID: 39065815 Free PMC article. Review.
-
Novel wine in an old bottle: Preventive and therapeutic potentials of andrographolide in atherosclerotic cardiovascular diseases.J Pharm Anal. 2023 Jun;13(6):563-589. doi: 10.1016/j.jpha.2023.05.010. Epub 2023 May 20. J Pharm Anal. 2023. PMID: 37440909 Free PMC article. Review.
-
An Integrated Network Pharmacology and RNA-seq Approach for Exploring the Protective Effect of Andrographolide in Doxorubicin-Induced Cardiotoxicity.Cardiovasc Drugs Ther. 2025 Jun;39(3):517-531. doi: 10.1007/s10557-024-07555-3. Epub 2024 Feb 24. Cardiovasc Drugs Ther. 2025. PMID: 38400848
-
Mathurameha ameliorates cardiovascular complications in high-fat diet/low-dose streptozotocin-induced type 2 diabetic rats: insights from histological and proteomic analysis.J Mol Histol. 2024 Dec;55(6):1177-1197. doi: 10.1007/s10735-024-10258-6. Epub 2024 Sep 4. J Mol Histol. 2024. PMID: 39227510
References
-
- Khan I, Khan F, Farooqui A, et al. Andrographolide exhibits anticancer potential against human colon cancer cells by inducing cell cycle arrest and programmed cell death via augmentation of intracellular reactive oxygen species level. Nutr Cancer. 2018;70:787–803. doi:10.1080/01635581.2018.1470649 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous